Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anne Marie L Inglis"'
Autor:
Michele Teufel, TransCelerate Biopharma Toolkits Core Team, Anne Marie L Inglis, M. Elmer, Kathyjo Shay, Catherine Sutherland, Stephen Yates, Cathy Florek, Sean Ludlam, Tanja Keiper, Karen L Johnson, T J Sharpe, Fabian Somers, Alison Greene, Lori Gabryelski
Publikováno v:
Therapeutic Innovation & Regulatory Science
Incorporating patient perspectives into clinical studies is recognized as important to the development of high-quality, safe, and effective fit-for-patient medicines. However, no widely accepted methodology to help design more patient-centered studie
Autor:
Martin I. Freed, Kathleen A. Thompson, Diane K. Jorkasky, Anne Marie L. Inglis, Robert Z. Harris, Dana Finnerty, Scott D. Patterson, Ann K. Miller
Publikováno v:
The Journal of Clinical Pharmacology. 39:1189-1194
To examine the effects of repeat oral dosing of rosiglitazone on the pharmacokinetics of nifedipine, a prototype CYP3A4 substrate, a randomized, open-label, crossover study was performed with two treatment phases separated by a washout period of at l
Autor:
Marcie J. Hursting, Robert A. DiCicco, Sunita B. Sheth, Alison M. Graham, Anne Marie L Inglis, David M. Tenero
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 59(13)
The potential pharmacokinetic interactions between argatroban and acetaminophen, lidocaine, or digoxin were examined. Three randomized crossover studies were conducted. In the first study, 11 subjects completed three sessions (with a five-day washout
Autor:
Martin I. Freed, Anne Marie L. Inglis, Ann K. Miller, Diane K. Jorkasky, Kathleen Thompson Culkin
Publikováno v:
European journal of clinical pharmacology. 57(2)
Objectives: To investigate whether treatment with acarbose alters the pharmacokinetics (PK) of coadministered rosiglitazone. Methods: Sixteen healthy volunteers (24–59-years old) received a single 8-mg dose of rosiglitazone on day 1, followed by 7
Autor:
Martin I. Freed, Scott D. Patterson, Ann K. Miller, Diane K. Jorkasky, Kathleen Thompson Culkin, Anne Marie L. Inglis, Dana Finnerty
Publikováno v:
Journal of clinical pharmacology. 41(6)
The effect of rosiglitazone (Avandia® [BRL 49653C]) on the pharmacokinetics of ethinylestradiol and norethindrone was evaluated after repeat dosing of rosiglitazone with an oral contraceptive (OC; Ortho-Novum® 1/35 containing noreth in drone 1 mg a